Press Releases for 2023

Results from Benefit of Microcor in Acute Decompensated Heart Failure (BMAD) Trial Presented as ACC.23/WCC Late-Breaking Clinical Trial

Monday, March 6, 2023 in Chelmsford, Mass.

First Patient Enrolled in REAL SSO2 Study to Evaluate Clinical Utility and Economic Value of ZOLL TherOx SSO2 Therapy

Tuesday, January 17, 2023 in Chelmsford, Mass.